Olympus Corp. Faces Probe on Fatal Infections
The hunt for a deadly superbug that sickened 22 patients at a Dutch hospital began just before noon on a spring day in 2012. Inside a lab in the tiny hamlet of Zoeterwoude, a technician carefully peeled back the tip of a state-of-the art medical scope. Watching him intently was a small group of hospital officials and executives from Olympus Corp., maker of the device. The Olympus technician found trouble right away. He spotted a...
Consumer Confidential: How a $500 Copay Turned Into a $3,900 Bill
Nobody wants to get sick. But if you do get sick, what you really don’t want is an illness that requires a so-called specialty drug. These are the high-priced drugs you’ve seen in the news lately, such as the hepatitis C drug Sovaldi. It costs an eye-popping $1,000 a pill. Or the tuberculosis drug cycloserine, which had cost about $500 for 30 capsules. It soared overnight to nearly $11,000 after being acquired by a new manufacturer...
